Back

Sulfite oxidase deficiency causes persulfidation loss and H2S release

Fu, C.-Y.; Kohl, J. B.; Liebsch, F.; D`Andrea, D.; Mai, M.; Mellis, A. T.; Kouroussis, E.; Ditroi, T.; Santamaria-Araujo, J. A.; Yeo, S. Y.; Endepols, H.; Krizkov, M.; Kozich, V.; Barayeu, U.; Akaike, T.; Hennermann, J. B.; Nagy, P.; Filipovic, M.; Schwarz, G.

2024-03-13 biochemistry
10.1101/2024.03.13.584820 bioRxiv
Show abstract

Sulfite oxidase (SOX) deficiency is a rare inborn error of cysteine metabolism resulting in severe neurological damage. In patients, sulfite accumulates to toxic levels causing a raise in downstream products S-sulfocysteine (SSC), mediating excitotoxicity, and thiosulfate, a catabolic intermediate/product of H2S metabolism. Here, we report a full-body knock-out mouse model for SOX deficiency (SOXD) with a severely impaired phenotype. Amongst the urinary biomarkers, thiosulfate showed a 45-fold accumulation in SOXD mice representing the major excreted S-metabolite. Consistently, we found increased plasma H2S, which was derived from sulfite-induced release from persulfides as demonstrated in vitro and in vivo. Mass spectrometric analysis of total protein persulfidome identified a major loss of persulfidation in 20% of the proteome affecting enzymes in amino acids and fatty acid metabolism. Urinary amino acid profiles indicate metabolic rewiring suggesting partial reversal of the TCA cycle thus identifying a novel contribution of H2S metabolism and persulfidation in SOXD.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.